AIM
PBH icon

Acrospire Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Acrospire Investment Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200
Closed -$11K – 1022
2017
Q2 		$11K Sell
200
-800
-80% -$42.9K 0.01% 1772
2017
Q1 		$56K Sell
1,000
-1,100
-52% -$60.7K 0.05% 837
2016
Q4 		$109K Buy
2,100
+100
+5% +$4.83K 0.04% 867
2016
Q3 		$97K Buy
2,000
+600
+43% +$30.3K 0.06% 582
2016
Q2 		$78K Sell
1,400
-3,200
-70% -$176K 0.06% 696
2016
Q1 		$246K Buy
+4,600
New +$227K 0.17% 132

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acrospire Investment Management's PBH Position: Q3 2017 in Review

Acrospire Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2017, closing a stake of 200 shares — an estimated $11K sold.

Acrospire Investment Management first reported a position in PBH in Q1 2016 and held it in 6 quarters. The position peaked at $246K in Q1 2016. 239 funds tracked by Wall St. Rank hold PBH as of Q3 2017.

  • Acrospire Investment Management reported no remaining Prestige Consumer Healthcare position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 200 Prestige Consumer Healthcare shares in Q3 2017, an estimated $11K.
  • Acrospire Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Prestige Consumer Healthcare position peaked at $246K in Q1 2016.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.